Scopio Labs Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
157
- Latest Deal Type
-
2ndary - Private
- Investors
-
19
Scopio Labs General Information
Description
Developer of a computational microscope and diagnostics equipment designed for easy and wide access to microscopy and diagnostics. The company's equipment offers a suite of fully digital diagnostic applications and imaging platforms that enhance clinical workflows with proper detection and diagnosis of blood-related diseases, enabling hematology labs to assess and analyze cell morphology at depth, making the diagnosis process more efficient and consistent across the continuum of care.
Contact Information
Website
www.scopiolabs.comCorporate Office
- Hasharon 10
- Tel Aviv 6618502
- Israel
Corporate Office
- Hasharon 10
- Tel Aviv 6618502
- Israel
Scopio Labs Timeline
Scopio Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 12. Later Stage VC (Series D) | 24-Jul-2025 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 20-Dec-2023 | Completed | Generating Revenue | |||
| 10. Debt - General | 31-Mar-2023 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 01-Aug-2022 | Completed | Generating Revenue | |||
| 8. Equity Crowdfunding | 20-Jan-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Debt - General | 05-Jan-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 28-Apr-2020 | $16.2M | $30.1M | Completed | Generating Revenue | |
| 4. Grant | 31-Aug-2018 | $66.5K | $13.9M | Completed | Generating Revenue |
Scopio Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred D2 | ||||||||
| Preferred D1 | ||||||||
| Preferred C-2 | ||||||||
| Preferred C-1 | ||||||||
| Preferred B2 | ||||||||
| Preferred B1 | ||||||||
| Preferred A2 | ||||||||
| Preferred A1 | 297,672 | $0.010000 | $20.16 | $20.16 | 1x | $20.16 | 5.69% | |
| Preferred A | 192,308 | $0.010000 | $7.28 | $7.28 | 1x | $7.28 | 3.68% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Scopio Labs Comparisons
Industry
Financing
Details
Scopio Labs Competitors (3)
One of Scopio Labs’s 3 competitors is CellaVision, a Formerly VC-backed company based in Lund, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CellaVision | Formerly VC-backed | Lund, Sweden | ||||
| ZEISS (Germany) | Formerly PE-Backed | Oberkochen, Germany | ||||
| Haag-Streit Group | Corporate Backed or Acquired | Koeniz, Switzerland |
Scopio Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Scopio Labs Patents
Scopio Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260341475-A1 | Automated routing of cytological smears for selective human review based on automatic cell classification | Pending | 25-Apr-2025 | ||
| WO-2026224675-A1 | Automated routing of cytological smears for selective human review based on automatic cell classification | Pending | 25-Apr-2025 | ||
| US-20240060965-A1 | Car therapy response prediction | Pending | 21-Aug-2022 | ||
| EP-4562433-A1 | Microscopy slide transfer between sample preparation and imaging devices | Pending | 25-Jul-2022 | ||
| EP-4562433-A4 | Microscopy slide transfer between sample preparation and imaging devices | Pending | 25-Jul-2022 | G01N35/00029 |
Scopio Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Scopio Labs Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Danaher Ventures | Corporate Venture Capital | Minority | ||
| Fortissimo Capital | PE/Buyout | Minority | ||
| Insight Capital Partners | PE/Buyout | Minority | ||
| Olive Tree Ventures | Venture Capital | Minority | ||
| Viola Growth | Growth/Expansion | Minority |
Scopio Labs FAQs
-
When was Scopio Labs founded?
Scopio Labs was founded in 2014.
-
Where is Scopio Labs headquartered?
Scopio Labs is headquartered in Tel Aviv, Israel.
-
What is the size of Scopio Labs?
Scopio Labs has 157 total employees.
-
What industry is Scopio Labs in?
Scopio Labs’s primary industry is Diagnostic Equipment.
-
Is Scopio Labs a private or public company?
Scopio Labs is a Private company.
-
What is Scopio Labs’s current revenue?
The current revenue for Scopio Labs is .
-
How much funding has Scopio Labs raised over time?
Scopio Labs has raised $154M.
-
Who are Scopio Labs’s investors?
Danaher Ventures, Fortissimo Capital, Insight Capital Partners, Olive Tree Ventures, and Viola Growth are 5 of 19 investors who have invested in Scopio Labs.
-
Who are Scopio Labs’s competitors?
CellaVision, ZEISS (Germany), and Haag-Streit Group are competitors of Scopio Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
